Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$270 Mln
Revenue (TTM)
$311 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.2 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.7
Industry P/E
73.01
EV/EBITDA
-5
Div. Yield
0 %
Debt to Equity
0.4
Book Value
$--
EPS
$-1.2
Face value
--
Shares outstanding
69,601,200
CFO
$-226.93 Mln
EBITDA
$-453.20 Mln
Net Profit
$-692.89 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Health Catalyst (HCAT)
| -48.4 | -10.1 | -18.0 | -43.1 | -34.3 | -34.2 | -- |
|
BSE Sensex
| 4.1 | -1.1 | 9.8 | 5.8 | 16.6 | 19.4 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|
|
Health Catalyst (HCAT)
| -23.5 | -12.9 | -73.2 | -9.0 | 25.4 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Health Catalyst (HCAT)
|
3.7 | 270.1 | 311.3 | -72.7 | -25.0 | -19.9 | -- | 0.7 |
| 13.3 | 9,151.6 | 6,685.2 | 715.6 | 16.4 | 12.3 | 12.9 | 1.5 | |
| 250.1 | 6,628.2 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 1.0 | |
| 232.0 | 6,212.8 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 0.9 | |
| 57.4 | 7,973.8 | 2,510.8 | 185.6 | 8.8 | 4.5 | 43.9 | 1.9 | |
| 71.1 | 8,774.1 | 12,669.0 | 407.0 | 5.4 | 11.8 | 21.9 | 2.7 | |
| 162.8 | 8,812.8 | 1,973.6 | -494.5 | -11.4 | -41 | -- | 9.3 | |
| 257.0 | 9,809.7 | 1,240.1 | 42.2 | 4.1 | 3.6 | 239 | 8.1 | |
| 117.7 | 14,455.8 | 3,357.5 | 396.9 | 16.3 | 5.4 | 41.5 | 2.6 | |
| 117.5 | 7,164.5 | 645.7 | -25.4 | 6.8 | -1.3 | -- | 3.6 |
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that... provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, ACOs, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah. Address: 10897 South River Front Parkway, South Jordan, UT, United States, 84095 Read more
CEO & Director
Mr. Daniel D. Burton
CEO & Director
Mr. Daniel D. Burton
Headquarters
South Jordan, UT
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Health Catalyst Inc (HCAT) stood at $ 1,231 Mln as on 31-Mar-25
The share price of Health Catalyst Inc (HCAT) is $3.65 (NASDAQ) as of 18-Jun-2025 16:00 EDT. Health Catalyst Inc (HCAT) has given a return of -34.27% in the last 3 years.
Health Catalyst Inc (HCAT) has a market capitalisation of $ 270 Mln as on 17-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Health Catalyst Inc (HCAT) is 0.72 times as on 17-Jun-2025, a 80% discount to its peers’ median range of 3.61 times.
Since, TTM earnings of Health Catalyst Inc (HCAT) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Health Catalyst Inc (HCAT) and enter the required number of quantities and click on buy to purchase the shares of Health Catalyst Inc (HCAT).
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, ACOs, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah. Address: 10897 South River Front Parkway, South Jordan, UT, United States, 84095
The CEO & director of Mr. Daniel D. Burton. is Health Catalyst Inc (HCAT), and CFO & Sr. VP is Mr. Daniel D. Burton.
There is no promoter pledging in Health Catalyst Inc (HCAT).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,134
|
|
|
981
|
|
|
921
|
|
|
906
|
|
|
889
|
|
|
823
|
|
|
742
|
|
|
671
|
|
|
671
|
| Health Catalyst Inc (HCAT) | Ratios |
|---|---|
|
Return on equity(%)
|
-19.86
|
|
Operating margin(%)
|
-25
|
|
Net Margin(%)
|
-23.34
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Health Catalyst Inc (HCAT) was $0 Mln.
$-0.16
(
